Rodrigo Do Lago in Winter Garden, Florida

Medical School: Sorry, his university is not listed
Graduation Year: 2002
The Primary Medical Specialty for Rodrigo Do Lago is listed as: Cardiovascular Disease (cardiology)
Approximate Years of Experience: 22
PAC (PECOS ID)#: 4587822663
NPI #: 1821269697
NPI Created On: 03/19/2008
NPI Last Updated Listed as: 08/19/2020
Primary Taxonomy Code: 207RI0011X
License Number:
ME113836
Listed Gender: Male

Forms of insurance accepted by include, but are not limited to:

• Celtic Insurance Company
• Humana
• Blue Cross Blue Shield
• Oscar Insurance Company of Florida
• Medicare

They are listed as accepting new patients in some locations.

Languages spoken by staff include: English, Portuguese, Spanish.

Services and Procedures include:

1. Replacement of aortic valve with prosthetic valve, accessed through the skin
2. Nuclear medicine study of vessels of heart using drugs or exercise multiple studies
3. Routine ekg using at least 12 leads including interpretation and report
4. Exercise or drug-induced heart and blood vessel stress test with ekg monitoring, physician supervision, interpretation, and report
5. Ultrasound examination of heart including color-depicted blood flow rate, direction, and valve function
6. Ultrasound examination of heart including color-depicted blood flow rate, direction, and valve function
7. Follow-up or limited ultrasound examination of heart
8. Insertion of catheter in left heart for imaging of blood vessels or grafts and left lower heart
9. New patient office or other outpatient visit, typically 45 minutes
10. New patient office or other outpatient visit, typically 60 minutes
11. Established patient office or other outpatient, visit typically 25 minutes
12. Established patient office or other outpatient, visit typically 40 minutes
13. Initial hospital inpatient care, typically 30 minutes per day
14. Subsequent hospital inpatient care, typically 25 minutes per day
15. Subsequent hospital inpatient care, typically 35 minutes per day
16. Technetium tc-99m sestamibi, diagnostic, per study dose
17. Injection, regadenoson, 0.1 mg